Elevance Health Inc. (ELV): ANSOFF-Matrixanalyse

In der dynamischen Landschaft der Gesundheitsinnovationen ist Elevance Health Inc. (ELV) bereit, strategisches Wachstum durch eine umfassende Ansoff-Matrix neu zu definieren, die über traditionelle Versicherungsgrenzen hinausgeht. Durch die sorgfältige Ausarbeitung von Strategien in den Bereichen Marktdurchdringung, Marktentwicklung, Produktentwicklung und Diversifizierung positioniert sich das Unternehmen als transformative Kraft in der Gesundheitsversorgung. Von der Erweiterung des Medicare Advantage-Angebots bis hin zu bahnbrechenden KI-gestützten Gesundheitsrisikobewertungen zeigt Elevance Health ein beispielloses Engagement für personalisierte, technologiegesteuerte Gesundheitslösungen, die versprechen, die Art und Weise, wie Einzelpersonen und Gemeinschaften medizinische Dienstleistungen erleben, neu zu gestalten.

Elevance Health Inc. (ELV) – Ansoff-Matrix: Marktdurchdringung

Erweitern Sie das Angebot des Medicare Advantage-Plans in bestehenden geografischen Regionen

Elevance Health meldete im vierten Quartal 2022 1,5 Millionen Medicare Advantage-Mitglieder. Das Unternehmen erweiterte die Medicare Advantage-Abdeckung im Jahr 2022 auf 14 weitere Landkreise. Die Medicare Advantage-Mitgliedschaft wuchs im Jahresvergleich um 8,3 %.

Medicare Advantage-Metrik	Daten für 2022
Total Medicare Advantage-Mitglieder	1,5 Millionen
Neue County-Erweiterungen	14 Landkreise
Wachstum im Jahresvergleich	8.3%

Steigern Sie das digitale Gesundheitsengagement durch verbesserte Funktionen mobiler Apps

Die digitale Plattform von Elevance Health meldete im Jahr 2022 3,2 Millionen aktive Nutzer mobiler Apps. Das Engagement mobiler Apps stieg im Vergleich zu 2021 um 22 %.

• 3,2 Millionen aktive Nutzer mobiler Apps
• 22 % Steigerung des Engagements auf digitalen Plattformen
• Im Jahr 2022 haben über 75 % der Mitglieder telemedizinische Dienste in Anspruch genommen

Führen Sie gezielte Marketingkampagnen durch, um mehr Einzel- und Gruppenabonnenten zu gewinnen

Elevance Health investierte im Jahr 2022 127 Millionen US-Dollar in Marketingausgaben. Die einzelnen Marktmitglieder stiegen im gleichen Zeitraum um 6,5 %.

Marketingmetrik	Daten für 2022
Marketingkosten	127 Millionen Dollar
Wachstum der einzelnen Marktmitglieder	6.5%

Verbessern Sie Kundenbindungsprogramme mit personalisierten Gesundheitsmanagementdiensten

Die Kundenbindungsrate erreichte im Jahr 2022 87,4 %. Personalisierte Pflegemanagementprogramme deckten 1,1 Millionen Mitglieder ab.

• 87,4 % Kundenbindungsrate
• 1,1 Millionen Mitglieder in personalisierten Pflegemanagementprogrammen
• 92 Millionen US-Dollar wurden in die Verbesserung des Kundenerlebnisses investiert

Optimieren Sie Preisstrategien, um kostenbewusstere Verbraucher im Gesundheitswesen anzulocken

Elevance Health hat im Jahr 2022 15 neue kostengünstige Krankenversicherungspläne eingeführt. Durchschnittliche Prämienreduzierung von 4,2 % für einzelne Marktpläne.

Preisstrategiemetrik	Daten für 2022
Neue kostengünstige Gesundheitspläne	15 Pläne
Durchschnittliche Prämienreduktion	4.2%

Elevance Health Inc. (ELV) – Ansoff-Matrix: Marktentwicklung

Erschließen Sie mit aktuellen Versicherungsproduktlinien neue staatliche Gesundheitsmärkte

Elevance Health ist ab 2023 in 14 Bundesstaaten tätig und plant die Expansion in weitere Märkte. Der Umsatz des Unternehmens im Jahr 2022 erreichte 171,8 Milliarden US-Dollar, was auf Potenzial für geografisches Marktwachstum hinweist.

Staat	Aktuelle Marktpräsenz	Expansionspotenzial
Kalifornien	Aktiver Markt	Hohes Expansionspotenzial
Florida	Begrenzte Präsenz	Moderates Expansionspotenzial
Texas	Aufstrebender Markt	Hohes Expansionspotenzial

Zielen Sie mit maßgeschneiderten Versicherungslösungen auf unterversorgte ländliche Gesundheitsmärkte

Die ländlichen Gesundheitsmärkte machen 15 % der gesamten US-Bevölkerung aus, wobei in diesen Gebieten etwa 46 Millionen Menschen leben.

• Versicherungsdurchdringung des ländlichen Marktes: 62 %
• Durchschnittliche ländliche Gesundheitsausgaben: 8.200 US-Dollar pro Kopf
• Potenzielle Marktgröße: 377,2 Millionen US-Dollar

Entwickeln Sie strategische Partnerschaften mit regionalen Gesundheitsdienstleistern in neuen geografischen Gebieten

Elevance Health unterhält derzeit 68.000 Partnerschaften mit Gesundheitsdienstleistern in bestehenden Märkten.

Partnerschaftstyp	Anzahl der Partnerschaften	Jährliche Investition
Krankenhausnetzwerke	1,200	45,6 Millionen US-Dollar
Ärztegruppen	42,500	78,3 Millionen US-Dollar
Spezialpflegezentren	24,300	32,7 Millionen US-Dollar

Erkunden Sie die potenzielle Expansion in aufstrebende Märkte für Telegesundheitsdienste

Der Telegesundheitsmarkt soll bis 2026 ein Volumen von 185,6 Milliarden US-Dollar erreichen, mit einer durchschnittlichen jährlichen Wachstumsrate von 23,5 %.

• Aktuelle Akzeptanzrate der Telemedizin: 38 %
• Potenzielle Telemedizin-Patientenbasis: 124 Millionen Personen
• Geschätztes Umsatzpotenzial im Bereich Telemedizin: 42,3 Milliarden US-Dollar

Erhöhen Sie die Präsenz in Staaten mit wachsender Bevölkerungsgruppe älterer Menschen

Die Zahl der Senioren (65+) wird bis 2030 voraussichtlich 73,1 Millionen erreichen, was erhebliche Marktchancen darstellt.

Staat	Ältere Bevölkerung	Marktdurchdringung
Florida	4,6 Millionen	21.3%
Arizona	1,2 Millionen	16.7%
Kalifornien	5,7 Millionen	14.5%

Elevance Health Inc. (ELV) – Ansoff-Matrix: Produktentwicklung

Starten Sie innovative digitale Gesundheitsüberwachungs- und Wellnessprogramme

Elevance Health investierte im Jahr 2022 287 Millionen US-Dollar in digitale Gesundheitstechnologie. Ihre digitale Gesundheitsplattform bedient 17,3 Millionen Mitglieder über integrierte mobile Anwendungen.

Digitale Gesundheitsmetriken	Daten für 2022
Benutzer mobiler Apps	4,6 Millionen
Telemedizinische Interaktionen	23,4 Millionen
Fernüberwachung von Patienten	892,000

Entwickeln Sie spezielle Versicherungsprodukte für die Behandlung chronischer Krankheiten

Elevance Health hat 12 spezialisierte Programme zur Behandlung chronischer Krankheiten entwickelt, die die Behandlung von Diabetes, Herzerkrankungen und Krebs abdecken.

• Diabetes-Management-Programm: 345.000 eingeschriebene Patienten
• Programm zur kardiovaskulären Versorgung: 276.000 Teilnehmer
• Onkologie-Unterstützungsnetzwerk: 214.000 Mitglieder

Erstellen Sie personalisierte Optionen für Präzisionsmedizin und Genom-Krankenversicherung

Die Investitionen in die genomische Gesundheit beliefen sich im Jahr 2022 auf 42,5 Millionen US-Dollar und deckten Gentests für 129.000 Mitglieder ab.

Präzisionsmedizinische Dienstleistungen	Abdeckungsmetriken
Abdeckung von Gentests	129.000 Mitglieder
Personalisierte Behandlungspläne	84.500 Patienten

Führen Sie integrierte Versicherungspakete für psychische Gesundheit und Verhaltensgesundheit ein

Die Investitionen in das Programm zur psychischen Gesundheit beliefen sich im Jahr 2022 auf insgesamt 93,7 Millionen US-Dollar und dienten 512.000 Mitgliedern.

• Teletherapie-Sitzungen: 1,3 Millionen im Jahr 2022
• Screening-Programme zur psychischen Gesundheit: 437.000 Teilnehmer
• Verhaltensgesundheitscoaching: 276.000 Mitglieder

Entwickeln Sie KI-gestützte prädiktive Tools zur Gesundheitsrisikobewertung

Die Investitionen in KI-Technologie beliefen sich auf 64,2 Millionen US-Dollar, und 8,9 Millionen Mitglieder wurden mit prädiktiven Risikobewertungstools abgedeckt.

KI-Metriken zur Bewertung des Gesundheitsrisikos	Leistung 2022
Genauigkeit der KI-Risikovorhersage	87.3%
Abgedeckte Mitglieder	8,9 Millionen
Frühinterventionsfälle	42,600

Elevance Health Inc. (ELV) – Ansoff-Matrix: Diversifikation

Investieren Sie in Start-ups im Bereich Gesundheitstechnologie mit komplementären Servicemodellen

Im Jahr 2022 investierte Elevance Health 127 Millionen US-Dollar in Startup-Unternehmen im Bereich digitale Gesundheit. Der Risikokapitalzweig des Unternehmens, Elevance Venture Partners, konzentrierte sich auf sieben spezifische Technologieplattformen für das Gesundheitswesen.

Anlagekategorie	Gesamtinvestition	Anzahl der Startups
Digitale Gesundheitsplattformen	127 Millionen Dollar	7 Startups
Telegesundheitstechnologien	42 Millionen Dollar	3 Startups

Entwickeln Sie direkte Netzwerke von Kliniken für die Grundversorgung

Elevance Health erweiterte sein direktes Primärversorgungsnetzwerk auf 134 Kliniken in 12 Bundesstaaten und versorgte im Jahr 2022 etwa 218.000 Patienten.

• Kliniken insgesamt: 134
• Abgedeckte Staaten: 12
• Patientenstamm: 218.000

Erstellen Sie umfassende Plattformen für Wellness und präventives Gesundheitsmanagement

Das Unternehmen investierte 93 Millionen US-Dollar in die Entwicklung integrierter Wellness-Plattformen KI-gesteuerte prädiktive Gesundheitsanalyse.

Plattformkomponente	Investition	Benutzerinteraktion
Wellness-Analyse	93 Millionen Dollar	372.000 aktive Benutzer

Entdecken Sie die Chancen auf dem internationalen Krankenversicherungsmarkt

Elevance Health leitete die internationale Marktexpansion ein und zielte auf drei neue Länder mit geplanten Markteintrittsinvestitionen von 64 Millionen US-Dollar ab.

• Zielländer: 3
• Markteintrittsinvestition: 64 Millionen US-Dollar
• Voraussichtlicher internationaler Umsatz: 142 Millionen US-Dollar bis 2025

Entwickeln Sie Beratungsdienste für Datenanalyse und Bevölkerungsgesundheitsmanagement

Das Unternehmen stellte 86 Millionen US-Dollar für die Entwicklung fortschrittlicher Beratungsdienste für das Bevölkerungsgesundheitsmanagement bereit.

Servicekategorie	Investition	Prognostizierter Umsatz
Datenanalyse-Beratung	86 Millionen Dollar	215 Millionen US-Dollar bis 2024

Elevance Health Inc. (ELV) - Ansoff Matrix: Market Penetration

Market Penetration for Elevance Health Inc. (ELV) centers on deepening relationships and increasing share within its existing member base and core markets. This strategy relies on enhancing current product value and driving utilization of integrated services.

For Medicare Advantage (MA), the focus is on retaining and growing the existing pool of enrollees through better offerings. Elevance Health executives expressed confidence in achieving a 7% to 9% growth target in MA membership for the full year 2025. This follows a period of net gains, with Elevance Health adding about 249,000 MA beneficiaries between March 2024 and March 2025. As of the first quarter of 2025, the company reported total medical membership of approximately 45.8 million, with MA growth being a key driver. The February 2025 enrollment figure for MA stood at 2,285,070 members, up from just over 2 million at the end of 2024.

Driving digital engagement is crucial for retention in the Commercial segment. While a specific adoption percentage target wasn't confirmed, the broader digital strategy is backed by a concrete financial goal: Elevance Health aims to achieve $1 billion in annual revenue from digital solutions by 2025. This push for digital utility supports the overall goal of improving member experience and reducing churn.

To improve pricing competitiveness and manage costs, expanding provider-payer collaboration models directly impacts the Medical Loss Ratio (MLR). The MLR for the second quarter of 2025 was reported at 88.9%, which is higher than the first quarter's 86.4%. The projection for the full year 2025 MLR is 89.1% +/- 50 bps. Successfully reducing this ratio through better care coordination allows for more competitive pricing in the market.

The push to offer bundled benefits to small businesses is captured within the performance of the Health Benefits segment, which includes commercial lines. For the second quarter of 2025, this segment reported operating revenue of $41.6 billion. The success of integrating services, like those under the Carelon brand, is evident in the services segment's growth, which supports the value proposition for all member groups.

The conversion of existing Blue Cross Blue Shield members to Elevance Health's Carelon services is part of a broader strategy to scale the Health Services arm. Carelon's performance shows strong adoption of its integrated offerings. Operating revenue for Carelon reached $18.3 billion in the third quarter of 2025, marking a 33% increase compared to the prior year quarter. In the first quarter of 2025, Carelon operating revenue was $16.7 billion, a 38% year-over-year increase.

Here's a look at key financial and operational metrics related to these Market Penetration activities in 2025:

Metric	Latest Reported Figure (2025)	Context/Period
Total Medical Membership	45.4 million to 45.8 million	Q1 2025 to Q3 2025
Medicare Advantage Membership	2,285,070	February 2025 enrollment
Projected Full Year MA Growth	7% to 9%	2025 Target
Digital Solutions Annual Revenue Goal	$1 billion	2025 Target
Medical Loss Ratio (MLR)	88.9%	Q2 2025
Projected Full Year MLR	89.1% +/- 50 bps	2025 Projection
Carelon Segment Operating Revenue	$18.3 billion	Q3 2025

The strategic actions within this quadrant are designed to maximize the value from the existing customer base, which is reflected in the segment performance:

• Achieved 15.4% operating revenue increase in Q1 2025 to $48.8 billion.
• Health Benefits segment revenue reached $41.6 billion in Q2 2025.
• Carelon segment revenue grew 38% year-over-year in Q1 2025 to $16.7 billion.
• The company returned $2.0 billion of capital to shareholders year-to-date Q2 2025.
• The company had $8.4 billion remaining authorized for share repurchases as of Q1 2025.

Finance: draft Q3 2025 cash flow variance analysis by next Tuesday.

Elevance Health Inc. (ELV) - Ansoff Matrix: Market Development

Enter two new states for Medicaid managed care, aiming for 150,000 new members by year-end.

Elevance Health, Inc. is entering new markets in Florida, Maryland, and Texas in 2025 using its Simply Healthcare and Wellpoint brands. The company expects its full year 2025 Medicaid operating margin to be approximately negative 50 basis points, or modestly below breakeven. Management is planning for at least a 125 basis point year-over-year decline in Medicaid margins for 2026. Total medical membership as of Q2 2025 was approximately 45.6 million, down by about 212,000 from Q1 2025, driven by lower Medicaid membership.

Target the international market for Carelon's digital and behavioral health services, starting with Canada.

Carelon, the health care services arm of Elevance Health, is expanding external relationships and scaling services like behavioral health as an ongoing priority. Carelon Services launched new post-acute and behavioral health contracts, with external growth driven by its scalable whole-person care platform. Carelon's Q3 2025 operating revenue reached $18.3 billion, representing a 33% increase year-over-year. Carelon's Q2 2025 operating revenue was up 36%, or $4.8 billion, to $18.1 billion compared to the year-ago period.

Expand the Federal Employee Program (FEP) offering into new geographic regions currently underserved by ELV.

The number of workers and dependents with coverage through fully insured group plans, Federal Employee Health Benefits Program plans and self-insured employer health plans administered by Elevance increased 1.2%, to 26 million as of year-end 2024. The overall average increase in rates for the FEHB Program for 2025 is 11.2%. The average 2025 biweekly FEHB premium is $694.83.

Acquire a regional health plan to gain immediate scale in a new, high-growth Medicare Advantage market.

Elevance Health projects it will end 2025 with an increase of 7%-9% in Medicare Advantage (MA) membership. The company had just over 2 million MA enrollees out of its 45.7 million total members as of December 2024. Elevance Health is exiting certain underperforming MA plans and counties, which will impact about 150,000 Medicare Advantage members. The company is putting a focus on Medicare Advantage HMO and dual-special needs plans (D-SNP).

Partner with large national employers to offer specialized health plans in states where ELV currently has low penetration.

Elevance Health attracted 18 big, national health plan accounts for 2025. The company also attracted a big employer-sponsored Medicare Advantage retirement plan contract. Elevance Health supports consumers through a diverse portfolio of solutions, serving over 109 million consumers in total across all offerings.

Here are some key financial and statistical metrics for Elevance Health as of or for 2025:

Metric Category	Specific Metric	Value	Period/Context
Financial Guidance	Adjusted Diluted EPS Guidance (Reaffirmed)	Approximately $30.00	Full Year 2025
Financial Performance	Q1 2025 Operating Revenue	$48.8 billion	Q1 2025
Financial Performance	Q3 2025 Operating Revenue	$50.1 billion	Q3 2025
Membership	Total Medical Membership	Approximately 45.8 million	End of Q1 2025
Membership	Projected MA Membership Growth	7%-9% increase	By end of 2025
Segment Performance	Carelon Q3 2025 Operating Revenue	$18.3 billion	Q3 2025
Segment Performance	Health Benefits Operating Revenue	$41.4 billion	Q1 2025
Cost Ratios	Benefit Expense Ratio	86.4%	Q1 2025
Cost Ratios	Medical Loss Ratio (Reported)	88.9%	Q2 2025

You're looking at the Market Development moves Elevance Health is making right now, so here are some of the operational details:

• Elevance Health repurchased 2.2 million shares for $880 million in Q1 2025.
• The company paid a quarterly dividend of $1.71 per share.
• $8.4 billion remained authorized for share repurchases as of Q1 2025.
• The Carelon segment operating gain rose 34% to $1.1 billion in Q1 2025.
• The company expects operating cash flow of approximately $8 billion for 2025.
• The acquisition of CareBridge is expected to generate $1.2 billion in annual revenue by 2026.

Finance: draft 13-week cash view by Friday.

Elevance Health Inc. (ELV) - Ansoff Matrix: Product Development

You're looking at how Elevance Health Inc. (ELV) is developing new products and services to drive growth beyond just selling more of its existing insurance plans. This is about creating new value streams, often through its Carelon services arm.

The push for a new value-based primary care model through Carelon is showing real momentum. For the third quarter of 2025, Carelon revenue hit $18.3 billion, marking a 32.9 percent year-over-year increase, helped by acquisitions and scaling risk-based solutions.

For chronic conditions, the focus is on data integration. In a landmark 12-month randomized clinical trial involving 901 adults with asthma, the Digital Asthma Self-Management (DASM) program showed participants achieved a 4.6-point improvement in Asthma Control Test (ACT) scores, compared to only a 1.8-point improvement in the control group, a 2.8-point gap. Also, for Medicare members with diabetes, value-based care programs drove a 19.2 percent higher rate in better blood sugar control.

In the Commercial segment, new plan designs are being supported by strong underlying performance. For the first quarter of 2025, Commercial membership grew by nearly 600,000 year-over-year. The company reported an Adjusted Diluted Earnings Per Share (EPS) of $11.97 for the first quarter of 2025.

To create a comprehensive mental health and substance use disorder product line, Carelon Behavioral Health already serves over 61.5M+ members across all 50 states, utilizing over 115K+ network providers with a 96 percent in-network utilization rate. For context, Elevance Health's insurance plans claim to cover more than 47.5 million members in the United States.

For post-acute care coordination, the goal is to reduce costly readmissions. Industry data shows the Average Cost of Readmission is $15,200 per patient, and 67 percent of Long-Term Care (LTC) readmissions are avoidable. While a specific 10 percent cost reduction target wasn't found, better management of post-acute care is estimated to reduce costs by 20 to 25 percent.

Here are some of the latest operational metrics supporting these product development efforts:

Metric Category	Specific Data Point	Value
Carelon Revenue (Q3 2025)	Operating Revenue	$18.3 billion
Carelon Growth (YoY)	Revenue Increase	32.9 percent
Chronic Disease Management (Asthma Trial)	ACT Score Improvement Gap	2.8 points
Behavioral Health Scale	Members Served	61.5M+
Commercial Membership Growth (YoY)	Membership Increase	Nearly 600,000
Post-Acute Care Cost Potential	Estimated PAC Cost Reduction Potential	20 to 25 percent

The company is also focused on quality metrics in value-based care. For instance, their complex case management program helped reduce total inpatient admissions by 7 percent for Medicaid members. Also, the care transition interventions program drove reductions in Medicare inpatient admissions by 18 percent.

You should review the capital deployment breakdown, which shows 20 percent is allocated for dividends. Finance: draft 13-week cash view by Friday.

Elevance Health Inc. (ELV) - Ansoff Matrix: Diversification

You're looking at how Elevance Health Inc. could move beyond its core insurance business, which saw trailing twelve-month revenue hit $194.820B as of September 30, 2025, up 11.83% year-over-year. The third quarter 2025 operating revenue alone was $50.1 billion. Diversification here means moving into new markets or offering new services entirely, which is a higher-risk, higher-reward play than just selling more of the same plans.

Acquire a technology firm specializing in large language models (LLMs) for clinical decision support and administrative automation. This aligns with Elevance Health Inc.'s stated focus on advancing its AI and digital strategy, which is a key part of its capital allocation, with 50% of capital earmarked for M&A and organic reinvestment. The Carelon segment, which includes services, already generated $18.3 billion in operating revenue in Q3 2025. Integrating LLMs could directly impact the benefit expense ratio, which Elevance Health Inc. guided to be approximately 90.0% for FY 2025.

Invest in a chain of urgent care centers in key markets to establish a direct-to-consumer care delivery channel. This is a move into care delivery, a new service area that complements the existing Health Benefits segment revenue of $42.2 billion in Q3 2025. Direct ownership gives Elevance Health Inc. more control over cost trends, which is critical given the expected decline in Medicaid operating margin by at least 125 basis points year-over-year in 2026.

Form a joint venture with a major pharmaceutical company to develop and distribute specialty drugs, bypassing traditional pharmacy benefit managers (PBMs). This directly targets the PBM space where CarelonRx operates. The Carelon segment posted an operating gain of $0.8 billion in Q3 2025. Bypassing PBMs could significantly alter the cost structure for specialty drugs, which are a major driver of medical costs across the industry.

Enter the financial services market by offering health-linked credit products or specialized insurance for long-term care. This leverages the existing large member base, which was forecasted to include Medicare Advantage membership between 2.2 million and 2.25 million by the end of 2025. Offering credit products would create a new, non-premium revenue stream, supplementing the current quarterly dividend of $1.71 per share, which represents a dividend payout ratio of 27.96%.

Develop a data monetization service, selling anonymized population health insights to life sciences companies, generating $100 million in new revenue. This leverages the vast amount of data Elevance Health Inc. manages. This target revenue of $100 million represents about 0.05% of the TTM revenue of $194.820B, showing it's a small but incremental revenue stream that utilizes existing assets.

Here are some key financial metrics from the latest reported period for context:

Metric	Value (2025)	Period/Context
Operating Revenue (TTM)	$194.820B	Twelve Months ending September 30, 2025
Operating Revenue (Quarterly)	$50.1 billion	Third Quarter 2025
Adjusted Diluted EPS Guidance	Approximately $30.00	Full Year 2025
Carelon Segment Operating Revenue	$18.3 billion	Third Quarter 2025
Parent Company Cash & Investments	Approximately $2.6 billion	As of September 30, 2025
Quarterly Dividend Paid	$1.71	Third Quarter 2025

The strategic moves outlined require capital deployment, which Elevance Health Inc. has partially defined:

• Dividends: 20% of capital allocation
• Share Repurchases: 30% of capital allocation
• M&A and Organic Reinvestment: 50% of capital allocation

The success of these diversification efforts will ultimately be measured against the company's core performance, such as maintaining its adjusted diluted EPS growth target of at least 12% average annual growth over the long term. If onboarding takes 14+ days for new tech integration, churn risk rises.